Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of
allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with …

Stem cell transplantation is being used to treat a number of hematologic malignancies as
well as hematologic and immune deficiency states. The ages of patients being offered this …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

Steroid refractory chronic graft-versus-host disease (cGVHD) is associated with a significant
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …

Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that occurs
frequently after allogeneic hematopoietic cell transplantation (HCT). Most cases are …

Abstract Tacrolimus (FK-506) is an immunosuppressant agent that acts by a variety of
different mechanisms which include inhibition of calcineurin. It is used as a therapeutic …

A joint working group established by the Haemato‐oncology subgroup of the B ritish C
ommittee for S tandards in H aematology (BCSH) and the B ritish S ociety for B one M arrow …

There is no consistently effective therapy for patients with steroid-refractory acute graft-
versus-host disease (GVHD). Various alternative approaches have been tested, including …

Chronic graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in long-
term survivors of allogeneic stem cell transplantation. The immunopathogenesis of chronic …

The Tenth Edition of the Handbook of Clinical Drug Data continues a long tradition of
providing clinically relevant, well-referenced drug information compiled by expert clinicians …